0
Your cart

Your cart is empty

Books > Earth & environment > The environment > Pollution & threats to the environment

Buy Now

Biomarkers in Risk Assessment - Validity and Validation (Paperback) Loot Price: R1,083
Discovery Miles 10 830
Biomarkers in Risk Assessment - Validity and Validation (Paperback): Who?

Biomarkers in Risk Assessment - Validity and Validation (Paperback)

Who?; Ilo, Unep

Series: Environmental Health Criteria, No. 222

 (sign in to rate)
Loot Price R1,083 Discovery Miles 10 830 | Repayment Terms: R101 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This publication seeks to provide a framework for selecting and validating biomarkers for risk assessment. Initial chapters consider the role of biomarkers in risk assessment and their validity. A biomarker is any substance, structure or process that can be measured in the body or its products, and influence or predict the incidence of outcome or disease. Biomarkers can be classified into markers of exposure, effect and susceptibility. If biomarkers are to contribute to environmental and occupational health risk assessments, they have to be relevant and valid. Relevance refers to the appropriateness of biomarkers to provide information on questions of interest and importance to public and environmental health authorities and other decision-makers. The validity of a biomarker is a function of intrinsic qualities of the biomarker and characteristics of the analytic procedures. Additionally, three broad categories of validity can be distinguished: measurement validity, internal study validity and external validity. Measurement validity is the degree to which a biomarker indicates what it purports to indicate. Internal study validity is the degree to which inferences drawn from a study actually pertain to study subjects and are true. External validity is the extent to which findings of a study can be generalized to apply to other populations. Subsequent chapters examine the validation of specific types of biomarkers and cross-species comparability. Supporting the main text are four extensive appendices covering the following subjects: 1. Biomarkers of exposure and effect for carcinogenicity 2. Biomarkers of exposure and effect for non-carcinogenic end-points 3. Measurement of drug metabolizing enzyme polymorphisms as indicators of susceptibility 4. Validation of biomarkers for environmental health research and risk assessment

General

Imprint: World Health Organization
Country of origin: Switzerland
Series: Environmental Health Criteria, No. 222
Release date: 2001
First published: February 2001
Producers: Who?
Authors: Ilo • Unep
Dimensions: 229 x 152 x 13mm (L x W x T)
Format: Paperback - Trade
Pages: 256
ISBN-13: 978-92-4-157222-4
Categories: Books > Medicine > Other branches of medicine > Pharmacology > Medical toxicology
Books > Earth & environment > The environment > Pollution & threats to the environment > General
Books > Medicine > General issues > Public health & preventive medicine > Personal & public health > Environmental factors
LSN: 92-4-157222-1
Barcode: 9789241572224

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners